Hadas Tamir

3.1k total citations · 3 hit papers
19 papers, 1.2k citations indexed

About

Hadas Tamir is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Hadas Tamir has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Hadas Tamir's work include SARS-CoV-2 and COVID-19 Research (11 papers), Poxvirus research and outbreaks (6 papers) and Herpesvirus Infections and Treatments (5 papers). Hadas Tamir is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Poxvirus research and outbreaks (6 papers) and Herpesvirus Infections and Treatments (5 papers). Hadas Tamir collaborates with scholars based in Israel, United States and Japan. Hadas Tamir's co-authors include Nir Paran, Tomer Israely, Hagit Achdout, Sharon Melamed, Yfat Yahalom-Ronen, Shay Weiss, Ofir Israeli, Adi Beth-Din, Yaara Finkel and Aharon Nachshon and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hadas Tamir

19 papers receiving 1.1k citations

Hit Papers

The coding capacity of SARS-CoV-2 2019 2026 2021 2023 2020 2019 2021 100 200 300

Peers

Hadas Tamir
Hadas Tamir
Citations per year, relative to Hadas Tamir Hadas Tamir (= 1×) peers Sharon Melamed

Countries citing papers authored by Hadas Tamir

Since Specialization
Citations

This map shows the geographic impact of Hadas Tamir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadas Tamir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadas Tamir more than expected).

Fields of papers citing papers by Hadas Tamir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadas Tamir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadas Tamir. The network helps show where Hadas Tamir may publish in the future.

Co-authorship network of co-authors of Hadas Tamir

This figure shows the co-authorship network connecting the top 25 collaborators of Hadas Tamir. A scholar is included among the top collaborators of Hadas Tamir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadas Tamir. Hadas Tamir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tamir, Hadas, Tal Noy-Porat, Sharon Melamed, et al.. (2024). Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nature Communications. 15(1). 3265–3265. 10 indexed citations
2.
Yahalom-Ronen, Yfat, Sharon Melamed, Boaz Politi, et al.. (2024). Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine. Vaccines. 12(5). 491–491. 7 indexed citations
3.
Tamir, Hadas, Michael Mor, David Hagin, et al.. (2023). Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens. iScience. 26(2). 105957–105957. 28 indexed citations
4.
Yahalom-Ronen, Yfat, Hadas Tamir, Sharon Melamed, et al.. (2023). VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants. Viruses. 15(6). 1364–1364. 2 indexed citations
5.
Erez, Noam, Hagit Achdout, Yfat Yahalom-Ronen, et al.. (2023). Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2. Current Issues in Molecular Biology. 45(10). 7944–7955. 5 indexed citations
6.
Noy-Porat, Tal, Hadas Tamir, Ron Alcalay, et al.. (2023). Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization. Microbiology Spectrum. 11(5). e0159823–e0159823. 7 indexed citations
7.
Fisher, Tal, Krishna Narayanan, Makoto Kuroda, et al.. (2022). Parsing the role of NSP1 in SARS-CoV-2 infection. Cell Reports. 39(11). 110954–110954. 43 indexed citations
8.
Cohen‐Dvashi, Hadas, Jonathan J. Weinstein, Michael Katz, et al.. (2022). Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern. iScience. 25(10). 105193–105193. 6 indexed citations
9.
Tamir, Hadas, Sharon Melamed, Noam Erez, et al.. (2022). Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection. Viruses. 14(2). 189–189. 26 indexed citations
10.
Milrot, Elad, Shlomi Lazar, Efi Makdasi, et al.. (2022). Insights from the Infection Cycle of VSV-ΔG-Spike Virus. Viruses. 14(12). 2828–2828. 1 indexed citations
11.
Elia, Uri, Srinivas Ramishetti, Ronit Rosenfeld, et al.. (2021). Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. 15(6). 9627–9637. 84 indexed citations
12.
Finkel, Yaara, Aharon Nachshon, Roni Winkler, et al.. (2021). SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature. 594(7862). 240–245. 160 indexed citations breakdown →
13.
Vitner, Einat B., Hagit Achdout, Roy Avraham, et al.. (2021). Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus. Journal of Biological Chemistry. 296. 100470–100470. 29 indexed citations
14.
Achdout, Hagit, Einat B. Vitner, Boaz Politi, et al.. (2021). Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity. Nature Communications. 12(1). 5819–5819. 50 indexed citations
15.
Melamed, Sharon, Boaz Politi, Ettie Grauer, et al.. (2021). Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination Efficacy. Frontiers in Bioengineering and Biotechnology. 9. 737627–737627. 1 indexed citations
16.
Finkel, Yaara, Orel Mizrahi, Aharon Nachshon, et al.. (2020). The coding capacity of SARS-CoV-2. Nature. 589(7840). 125–130. 382 indexed citations breakdown →
17.
Erez, Noam, Hagit Achdout, Elad Milrot, et al.. (2019). Diagnosis of Imported Monkeypox, Israel, 2018. Emerging infectious diseases. 25(5). 980–983. 302 indexed citations breakdown →
18.
Israely, Tomer, Nir Paran, Noam Erez, et al.. (2019). Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains. Vaccines. 7(1). 19–19. 5 indexed citations
19.
Achdout, Hagit, Shlomo Lustig, Tomer Israely, et al.. (2017). Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models. Vaccine. 35(33). 4245–4254. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026